Stock Events

Stock Events

Silence Therapeutics (SLN) Q4 2024 Earnings

14NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.09

-0.06

-0.03

-0.01

Details

Expected EPS

-0.04379731

Actual EPS

-0.08513551

Surprise EPS

-0.04

Surprise Percent

+94.39%

Description

Silence Therapeutics (SLN) has reported earnings of -0.08513551 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.